As India gears up to begin a mega vaccination drive with two approved candidates - Bharat Biotech’s Covaxin and Pune-based Serum Institute’s Covishield, there are several pressing questions in citizens’ minds.
The government has approved two anti-viral drugs. While Favipiravir is for those with mild to moderate symptoms of coronavirus, Remdesivir is for patients on oxygen support.